These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9399623)

  • 21. Red and wet.
    van Westerloo DJ; Juffermans NP
    Neth J Med; 2010 May; 68(5):228-31. PubMed ID: 20508274
    [No Abstract]   [Full Text] [Related]  

  • 22. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
    Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of once-daily vancomycin for staphylococcal endocarditis.
    Marik PE
    Pharmacotherapy; 1998; 18(3):650-2. PubMed ID: 9620118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome.
    Blumenthal KG; Patil SU; Long AA
    Allergy Asthma Proc; 2012; 33(2):165-71. PubMed ID: 22525393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes.
    Lodise TP; McKinnon PS
    Pharmacotherapy; 2007 Jul; 27(7):1001-12. PubMed ID: 17594206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    Lin DF; Zhang YY; Wu JF; Wang F; Zheng JC; Miao JZ; Zheng LY; Sheng RY; Zhou X; Shen HH; Ijzerman MM; Croos-Dabrera RV; Sheng W
    Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
    Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum and synovial vancomycin concentrations following prophylactic administration in knee arthroplasty.
    Eshkenazi AU; Garti A; Tamir L; Hendel D
    Am J Knee Surg; 2001; 14(4):221-3. PubMed ID: 11703034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug reaction with eosinophilia and systemic symptoms and cytomegalovirus colitis.
    Krummenacher M; Banovic T; Kette F; Smith W; Hissaria P
    Ann Allergy Asthma Immunol; 2019 Oct; 123(4):401-403. PubMed ID: 31376489
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhaled vancomycin-induced allergic reaction in decontamination of respiratory tracts for allogeneic bone marrow transplantation.
    Kahata K; Hashino S; Imamura M; Mori A; Kobayashi S; Asaka M
    Bone Marrow Transplant; 1997 Dec; 20(11):1001-3. PubMed ID: 9422483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
    Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glycopeptides (vancomycin, teicoplanin)--their place in the antibacterial therapy of patients in a high-risk group].
    Beloborodova NV
    Anesteziol Reanimatol; 1998; (4):23-7. PubMed ID: 9770813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fever, rash, and pancytopenia following vancomycin rechallenge in the presence of ceftazidime.
    Shahar A; Berner Y; Levi S
    Ann Pharmacother; 2000 Feb; 34(2):263-4. PubMed ID: 10676837
    [No Abstract]   [Full Text] [Related]  

  • 35. Erythema multiforme to vancomycin.
    Padial MA; Barranco P; Lopez-Serrano C
    Allergy; 2000 Dec; 55(12):1201. PubMed ID: 11117283
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH; Hsu RB
    Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.
    Shorr AF; Kunkel MJ; Kollef M
    J Antimicrob Chemother; 2005 Nov; 56(5):923-9. PubMed ID: 16195255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of vancomycin in the treatment paradigm.
    Stevens DL
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S51-7. PubMed ID: 16323121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.
    Rubinstein E; Cammarata S; Oliphant T; Wunderink R;
    Clin Infect Dis; 2001 Feb; 32(3):402-12. PubMed ID: 11170948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment.
    Zuliani E; Zwahlen H; Gilliet F; Marone C
    Clin Nephrol; 2005 Aug; 64(2):155-8. PubMed ID: 16114793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.